Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


04.03.2019

3 AJNR Am J Neuroradiol
1 Childs Nerv Syst
4 Clin Cancer Res
1 J Clin Oncol
5 J Neurooncol
2 J Neuropathol Exp Neurol
2 Neuro Oncol
2 Neurosurgery
2 Oncogene
1 PLoS Genet
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. BAAL JD, Chen WC, Solomon DA, Pai JS, et al
    Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes.
    AJNR Am J Neuroradiol. 2019 Feb 28. pii: ajnr.A5996. doi: 10.3174/ajnr.A5996.
    PubMed     Text format     Abstract available

  2. HU LS, Yoon H, Eschbacher JM, Baxter LC, et al
    Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.
    AJNR Am J Neuroradiol. 2019 Feb 28. pii: ajnr.A5981. doi: 10.3174/ajnr.A5981.
    PubMed     Text format     Abstract available

  3. RODRIGUEZ D, Chambers T, Warmuth-Metz M, Aliaga ES, et al
    Evaluation of the Implementation of the Response Assessment in Neuro-Oncology Criteria in the HERBY Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
    AJNR Am J Neuroradiol. 2019 Feb 28. pii: ajnr.A5982. doi: 10.3174/ajnr.A5982.
    PubMed     Text format     Abstract available


    Childs Nerv Syst

  4. RICKLEFS FL, Fritzsche F, Winkler B, Meissner B, et al
    Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.
    Childs Nerv Syst. 2019 Feb 22. pii: 10.1007/s00381-019-04086.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. IPPEN FM, Alvarez-Breckenridge CA, Kuter BM, Fink AL, et al
    The dual PI3K/mTOR-pathway inhibitor GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases.
    Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3049.
    PubMed     Text format     Abstract available

  6. HALL PE, Lewis R, Syed N, Shaffer R, et al
    A Phase I study of pegylated arginine deiminase (pegargiminase), cisplatin and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma.
    Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3729.
    PubMed     Text format     Abstract available

  7. LASSMAN AB, Roberts-Rapp LA, Sokolova I, Song M, et al
    Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma.
    Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3034.
    PubMed     Text format     Abstract available

  8. TOMASZEWSKI W, Sanchez-Perez L, Gajewski TF, Sampson JH, et al
    Brain Tumor Micro-environment and Host State - Implications for Immunotherapy.
    Clin Cancer Res. 2019 Feb 25. pii: 1078-0432.CCR-18-1627.
    PubMed     Text format     Abstract available


    J Clin Oncol

  9. SHINDE A, Li R, Amini A, Glaser S, et al
    Can Immunotherapy Replace Radiotherapy in Melanoma Brain Metastases?
    J Clin Oncol. 2019 Feb 26:JCO1801982. doi: 10.1200/JCO.18.01982.
    PubMed     Text format    


    J Neurooncol

  10. CAI M, Hou B, Luo L, Zhang B, et al
    Trans-eyebrow supraorbital keyhole approach to tuberculum sellae meningiomas: a series of 30 cases with long-term visual outcomes and recurrence rates.
    J Neurooncol. 2019 Feb 22. pii: 10.1007/s11060-019-03128.
    PubMed     Text format     Abstract available

  11. MUSKENS IS, Hansen HM, Smirnov IV, Molinaro AM, et al
    Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.
    J Neurooncol. 2019 Feb 22. pii: 10.1007/s11060-019-03119.
    PubMed     Text format     Abstract available

  12. WANG YC, Lee CC, Takami H, Shen S, et al
    Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors.
    J Neurooncol. 2019 Feb 25. pii: 10.1007/s11060-019-03131.
    PubMed     Text format     Abstract available

  13. YAO J, Tan CHP, Schlossman J, Chakhoyan A, et al
    pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma.
    J Neurooncol. 2019 Feb 26. pii: 10.1007/s11060-019-03132.
    PubMed     Text format     Abstract available

  14. CESCHIN R, Kocak M, Vajapeyam S, Pollack IF, et al
    Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.
    J Neurooncol. 2019 Feb 27. pii: 10.1007/s11060-019-03133.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  15. TEGLASI V, Csury DT, Dezso K, Bugyik E, et al
    Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns.
    J Neuropathol Exp Neurol. 2019 Feb 28. pii: 5366830. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. TORRE M, Meredith DM, Dubuc A, Solomon DA, et al
    Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    J Neuropathol Exp Neurol. 2019 Feb 9. pii: 5366829. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neuro Oncol

  17. KOTECHA R, Kim JM, Miller JA, Juloori A, et al
    The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis.
    Neuro Oncol. 2019 Feb 23. pii: 5364051. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. MIKLJA Z, Pasternak A, Stallard S, Nicolaides T, et al
    Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.
    Neuro Oncol. 2019 Feb 26. pii: 5364813. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  19. MCCARTHY D, Starke RM, Sheinberg D, Connolly ES, et al
    Treatment Synergy for Glioblastoma Multiforme with SynergySeq.
    Neurosurgery. 2019 Feb 27. pii: 5365775. doi: 10.1093.
    PubMed     Text format    

  20. AL-HOLOU WN, Hodges TR, Everson RG, Freeman J, et al
    Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.
    Neurosurgery. 2019 Feb 25. pii: 5364163. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  21. YOO KC, Suh Y, An Y, Lee HJ, et al
    Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.
    Oncogene. 2018;37:3317-3328.
    PubMed     Text format     Abstract available

  22. CONTRERAS-ZARATE MJ, Day NL, Ormond DR, Borges VF, et al
    Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Oncogene. 2019 Feb 22. pii: 10.1038/s41388-019-0756.
    PubMed     Text format     Abstract available


    PLoS Genet

  23. POULOS RC, Wong YT, Ryan R, Pang H, et al
    Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    PLoS Genet. 2018;14:e1007779.
    PubMed     Text format     Abstract available


    PLoS One

  24. VENTERO MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, et al
    Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    PLoS One. 2019;14:e0212581.
    PubMed     Text format     Abstract available

  25. LUHTALA N, Hunter T
    Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture.
    PLoS One. 2018;13:e0203290.
    PubMed     Text format     Abstract available

  26. BERTERO L, Anfossi V, Osella-Abate S, Disanto MG, et al
    Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    PLoS One. 2018;13:e0203570.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: